Congenital heart diseaseCohort study

The SIDECAR 2.0 (S-ICD registry in European paediatric and young adult patients with congenital heart defects 2.0): an analysis of European S-ICD clinical practice and its evolution in paediatric patients

EuropacePublished

  • Retrospective cohort study
  • international
  • multicentre
  • observational registry

Authors' conclusion

This multicentre S-ICD European registry in paediatric and young patients demonstrated favourable outcomes, low IAS, and complication rates.

Study context

Population
Paediatric and young adult patients with congenital heart defects (CHD), cardiomyopathies, channelopathies or idiopathic VF, Europemean age 15 ± 3 years
Participants
223 participants
Outcome
Safety and efficacy of subcutaneous implantable cardioverter-defibrillators (S-ICDs) (defibrillation efficacy, inappropriate and appropriate shocks, complications)

Main finding

As reported in the abstract

Defibrillation efficacy and appropriate shocks · median follow-up 28 (IQR: 12-55) months

Acute defibrillation success

100%

Patients with appropriate shocks

41 (18%)

Appropriate shock rate at 5 years

26%

First shock effective, discrete episodes

92%

Observational data: associations, not effects.

Further findings

Implantation technique

Intermuscular implantation
65%
Two-incision technique
88%

Safety

Intraoperative complications

No intraoperative complications

Inappropriate shocks (IAS) and complications · 5 years

IAS rate
20%
Complication rate
5%
Older age, intermuscular pocket and two-incision technique associated with fewer complications

Original publication

The SIDECAR 2.0 (S-ICD registry in European paediatric and young adult patients with congenital heart defects 2.0): an analysis of European S-ICD clinical practice and its evolution in paediatric patients. Europace. Published 30 October 2025. doi:10.1093/europace/euaf276

Summarised from the published abstract; every number is checked against it